Introduction: Asian scientists have now increasingly begun to contribute to globalization; yet it is not clear whether publishing in the field of urology is paralleled by elevated cross-continental scientific publishing. Materials and Methods: An exemplary bibliometric analysis of urologic journals from 3 different continents was conducted between 2002 and 2012. Based on the ISI Web of Knowledge Journal Citation Reports, 2 urologic journals with similar impact factors (IFs) in 2013 were selected from Europe (‘British Journal of Urology International', ‘World Journal of Urology'), Asia (‘International Journal of Urology', ‘Asian Journal of Andrology') and North America (‘Urologic Oncology-Seminars and Original Investigations', ‘Urology'). The home continent of the journal, the workplace continental affiliation of the last author, article type (clinical, experimental or review) as well as the IF were documented. Results: Most authors published their manuscripts in journals from the same continent in which they worked. However, a significant increase in cross-continental publishing was apparent from 2002 to 2012. Asians publishing in North America increased from 17% in 2002 to 35% in 2012. Europeans also increased the number of articles they published in North American journals, while publications from North American authors were shifted towards both European and Asian journals. Experimental and clinical articles showed significant increases in cross-continental publishing, while review publishing showed no significant change. The average IF for authors from all 3 continents increased from 2002 to 2012 (p < 0.001). The largest increase in the IF was found for Asian authors (0.11 per year). Conclusions: Cross-continental publication significantly increased during the period from 2002 to 2012. The impact that the Asian authors have experienced was found to be gradually impacting the North American and European colleagues.

1.
Paraje G, Sadana R, Karam G: Public health. Increasing international gaps in health-related publications. Science 2005;308:959-960.
2.
May RM: Scientific wealth of nations. Science 1997;275:793-796.
3.
Ahmed Ali U, van der Sluis PC, Issa Y, Habaga IA, Gooszen HG, Flum DR, Algra A, Besselink MG: Trends in worldwide volume and methodological quality of surgical randomized controlled trials. Ann Surg 2013;258:199-207.
4.
Li Z, Wan X, Li X, Li J: Research output in immunology journals from Chinese authors: 10-year survey of literature. Immunol Invest 2010;39:206-218.
5.
Soteriades ES, Rosmarakis ES, Paraschakis K, Falagas ME: Research contribution of different world regions in the top 50 biomedical journals (1995-2002). FASEB J 2006;20:29-34.
6.
Micheli A, Di Salvo F, Lombardo C, Ugolini D, Baili P, A Pierotti M: Cancer research performance in the European Union: a study of published output from 2000 to 2008. Tumori 2011;97:683-689.
7.
Monge-Nájera J, Nielsen V: The countries and languages that dominate biological research at the beginning of the 21st century. Rev Biol Trop 2005;53:283-294.
8.
Soteriades ES, Falagas ME: Comparison of amount of biomedical research originating from the European Union and the United States. BMJ 2005;331:192-194.
9.
King DA: The scientific impact of nations. Nature 2004;430:311-316.
10.
Laurance WF: Second thoughts on who goes where in author lists. Nature 2006;442:26.
11.
Oelrich B, Peters R, Jung K: A bibliometric evaluation of publications in urological journals among European Union countries between 2000-2005. Eur Urol 2007;52:1238-1248.
12.
Sumathipala A, Siribaddana S, Patel V: Under-representation of developing countries in the research literature: ethical issues arising from a survey of five leading medical journals. BMC Med Ethics 2004;5:E5.
13.
Chen Y, Li J, Ai C, Duan Y, Wang L, Zhang M, Hopewell S: Assessment of the quality of reporting in abstracts of randomized controlled trials published in five leading Chinese medical journals. PLoS One 2010;5:e11926.
14.
Suh CO, Oh SJ, Hong ST: Korean association of medical journal editors at the forefront of improving the quality and indexing chances of its member journals. J Korean Med Sci 2013;28:648-650.
15.
Cho HJ, Chung JH, Jo JK, Kang DH, Cho JM, Yoo TK, Lee SW: Assessments of the quality of randomized controlled trials published in International Journal of Urology from 1994 to 2011. Int J Urol 2013;20:1212-1219.
16.
Landoni G, Bignami E, Nicolotti D, Pieri M, Silvetti S, Buratti L, Landoni P, John M, Zangrillo A: Publication trends in the journal of cardiothoracic and vascular anesthesia: a 10-year analysis. J Cardiothorac Vasc Anesth 2010;24:969-973.
17.
Purgato M, Cipriani A, Barbui C: Randomized trials published in Chinese or Western journals: comparative empirical analysis. J Clin Psychopharmacol 2012;32:354-361.
18.
Zhang D, Yin P, Freemantle N, Jordan R, Zhong N, Cheng KK: An assessment of the quality of randomised controlled trials conducted in China. Trials 2008;9:22.
19.
Sharrock G, Graf C, Fitzpatrick JM: The role of ethical publishing in promoting the evidence-based practice of urology. World J Urol 2011;29:319-324.
20.
van Weijen D: How to overcome common obstacles to publishing in English. Res Trends 2013;35:17-18.
21.
Man JP, Weinkauf JG, Tsang M, Sin DD: Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked general medical journals. Eur J Epidemiol 2004;19:811-817.
22.
Xu J, Mao ZG, Kong M, Hu LH, Ye CY, Xu CG, Rong S, Sun LJ, Wu J, Dai B, Chen DP, Zhu YX, Zhang YX, Zhang YQ, Zhao XZ, Mei CL: Scientific publications in nephrology and urology journals from Chinese authors in East Asia: a 10-year survey of the literature. PLoS One 2011;6:e14781.
23.
Gannon F: Address bias. EMBO Rep 2007;8:421.
24.
Editor's choice: Aspiring to be global. BMJ 2001;323:a.
25.
Barbor TF, Stenius K, Savva S, O'Reilly J: Publishing Addiction Science: A Guide for the Perplexed. Essex, Multi-Science Publishing Company, Ltd., 2008.
26.
Ha TC, Tan SB, Soo KC: The journal impact factor: too much of an impact? Ann Acad Med Singapore 2006;35:911-916.
27.
Andersen J, Belmont J, Cho CT: Journal impact factor in the era of expanding literature. J Microbiol Immunol Infect 2006;39:436-443.
28.
Mani J, Makarević J, Juengel E, Ackermann H, Nelson K, Haferkamp A, Blaheta RA: Publication of original research in urologic journals - a neglected orphan? PLoS One 2012;7:e52420.
29.
Li J, Gao XH, Bian Q, Guo ZY, Mei XB, Yu G, Wu H, Lai XL, Chen W: Comparative study of scientific publications in urology and nephrology journals originating from USA, China and Japan (2001-2010). PLoS One 2012;7:e42200.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.